20
total announcements
544497.BO · 15 min delayed
Anlon Healthcare Ltd
Anlon Healthcare Ltd has issued a corrigendum to the notice of its 13th Annual General Meeting (AGM) to be held on September 05, 2026, due to observations raised by BSE and NSE regarding the company's in-principle application for issue and allotment of shares on a preferential basis.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has published a newspaper advertisement for its 13th Annual General Meeting to be held on September 05, 2026, as per Regulation 30 read with Regulation 47 of the SEBI (LODR) Regulations, 2015.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, as per SEBI regulations. The report, issued by Crisil Ratings Limited, indicates that the company has utilized the IPO proceeds in line with the objects stated in the prospectus, with no deviations observed.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has announced the outcome of its Board meeting, where it has approved several matters, including the audited financial statements for FY 2026, appointment of a new director, regularization of another director, appointment of an internal auditor, and approval of remuneration of the cost auditor. The company has also approved the increase in authorized share capital and the adoption of share swap agreements for the acquisition of up to 44.94% shareholding in Apiqo Organics Private Limited and up to 47.41% shareholding in Bizotic Lifescience Private Limited.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has announced the fixing of a record date for its Annual General Meeting. The meeting will consider various matters, including the audited financial statements, appointment of a director, regularization of another director, and approval of share swap agreements with two companies. The company will also issue equity shares on a preferential basis to the identified shareholders of the two companies.
Anlon Healthcare Ltd
Anlon Healthcare Ltd's Board Meeting outcome includes approval of audited financial statements, appointment of a director, regularization of another director, appointment of an internal auditor, increase in authorized share capital, and adoption of share swap agreements for acquiring stakes in two companies.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has submitted a revised intimation under Regulation 30 of SEBI (LODR) Regulation, 2015, clarifying the percentage of acquisition in Apiqo Organics Private Limited and Bizotic Lifescience Private Limited.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has released the transcript of its Q1 FY27 earnings conference call, which was held on August 6, 2026. The company's EBITDA margin moderated to approximately 17% due to a sharp increase in raw material prices and the consolidation of operating expenses from its recent acquisition, Remember India Health links. Despite this, the company's total income for the quarter stood at 87.62 crore, a significant increase driven by the consolidation of its recent acquisition and organic growth in its core businesses. The company has completed the acquisition of a 63.98% stake in Remember India Health links, which provides access to over 30 formula dossiers.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has postponed its Board Meeting scheduled for August 11, 2026, to August 13, 2026, due to administrative reasons.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has executed Share Swap Agreements with certain shareholders of Apiqo Organics Private Limited and Bizotic Lifescience Private Limited to acquire up to 32.52% and 43.33% shareholding respectively in lieu of issuance and allotment of fresh equity shares on a preferential basis.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has announced the closure of its trading window for dealing in securities, effective from August 6, 2026, until 48 hours after the conclusion of its Board of Directors meeting on August 11, 2026.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 11/08/2026 to consider and approve various business items, including audited financial statements, director appointments, internal auditor appointment, remuneration of cost auditor, and related party transactions.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has announced the availability of the audio recording of its Q1/FY-27 earnings conference call on its website.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has announced the acquisition of Apiqo Bizotic Lifescience Pvt. Ltd. and Remember India Health Links Pvt. Ltd. to strengthen its position as an integrated pharmaceutical company. The acquisitions are expected to enhance the company's capacity, improve cost competitiveness, and accelerate growth.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has published its unaudited standalone financial results for the quarter ended June 30, 2026, showing a net loss of Rs. 725 million, compared to a net profit of Rs. 5,872 million in the previous quarter.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has announced an earnings conference call to discuss its audited financial results for the quarter ended June 30, 2026. The call will be held on August 6, 2026, at 4:00 PM IST. The discussion will be based on publicly available information and no unpublished price-sensitive information will be discussed.
Anlon Healthcare Ltd
Anlon Healthcare Limited has announced its unaudited Financial Results for Q1FY27, reporting a 163.02% year-on-year growth in consolidated Total Income to ₹87.62 Crore, 150.14% growth in EBITDA to ₹15.65 Crore, and 133.13% growth in Profit After Tax to ₹8.28 Crore. The company has strengthened its integrated pharmaceutical platform through strategic acquisitions, expanded its product portfolio, and improved operational synergies.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, along with a limited review report. The company has also authorized a share swap arrangement with shareholders of Apiqo Organics Private Limited and Bizotic LifeScience Private Limited to acquire a majority stake in these entities.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has announced the outcome of its Board Meeting, where the Board considered and approved the unaudited financial results for the quarter ended June 30, 2026, and also authorized the Chairman & Managing Director and/or Whole Time Director to enter into a share swap arrangement with the shareholders of Apiqo Organics Private Limited and Bizotic LifeScience Private Limited.
Anlon Healthcare Ltd
Anlon Healthcare Ltd has scheduled a board meeting on July 30, 2026, to consider and approve unaudited financial results for the quarter ended June 30, 2026, and to authorize a share swap arrangement with shareholders of Apiqo Organics Private Limited and Bizotic LifeScience Private Limited.